Novo Nordisk Still On The Lookout For Diabetes Innovations

 
• By Kevin Grogan

The Denmark-based major intends to build on its heritage in diabetes and is keen to hear from innovators in a space where prevalence is on the rise but is not being served by improved new products.

The world's largest insulin production facility at Kalundborg, Denmark (Novo Nordisk)

More from Deals

More from Therapy Areas